JOINT FILING AGREEMENT
Exhibit 99.2
In accordance with Rule 13d-1(k)(1)(iii) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of Amendment No. 2 to the Schedule 13D originally filed on March 10, 2010 (including additional amendments thereto) with respect to the Common Stock, $0.001 par value per share, of Orchid Cellmark Inc. This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: September 7, 2010
|
ACCIPITER LIFE SCIENCES FUND, LP
|
|
By:
|
Candens Capital, LLC
its general partner
|
|
By:
|
/s/ Xxxx Xxxxxxx | |
Xxxx Xxxxxxx, Managing Member
|
ACCIPITER LIFE SCIENCES FUND (OFFSHORE), LTD.
|
||
By:
|
its investment manager
|
|
By:
|
/s/ Xxxx Xxxxxxx | |
Xxxx Xxxxxxx, Managing Member
|
By:
|
/s/ Xxxx Xxxxxxx | |
Xxxx Xxxxxxx, Managing Member
|
CANDENS CAPITAL, LLC
|
||
By:
|
/s/ Xxxx Xxxxxxx | |
Xxxx Xxxxxxx, Managing Member
|
/s/ Xxxx Xxxxxxx | |
XXXX XXXXXXX
|